on 15/09/2016 15:56
on 14/09/2016 10:48
Study evaluating ESN364, a novel, non-hormonal small-molecule drug designed to block Hot Flashes avoiding Hormone Replacement Therapy (HRT), known to increase the incidence of cancer in menopausal women.
Mainstay Medical’s ReActiv8-B Clinical Trial for treatment of Chronic Low Back Pain enrols First Subject
on 14/09/2016 10:35
Trial to gather data in support of an application for US pre-market approval (PMA)
on 07/09/2016 10:50
on 19/07/2016 17:16